GO:0017096 acetylserotonin O-methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0017096 describes the enzymatic activity that converts N-acetylserotonin to melatonin using S-adenosyl-L-methionine as the methyl donor.
• The reaction is the final and rate-limiting step in melatonin biosynthesis, and it is catalyzed by acetylserotonin O-methyltransferase (ASMT), also known as hydroxyindole O-methyltransferase (HIOMT).
• In plants, caffeic acid O-methyltransferase (COMT) can also catalyze this reaction, demonstrating evolutionary conservation of the activity.
• ASMT/HIOMT activity is regulated at transcriptional and post-translational levels, and its dysfunction is linked to neuropsychiatric and metabolic phenotypes.
• Loss of ASMT activity reduces melatonin production, which has been associated with alcohol-related disorders, suicide, and arterial injury.
• CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect the causal role of ASMT in melatonin-related physiology and disease.
Description
Acetylserotonin O-methyltransferase activity (GO:0017096) is a molecular function that catalyzes the final step in melatonin biosynthesis: the transfer of a methyl group from S-adenosyl-L-methionine to N-acetylserotonin, yielding melatonin and S-adenosyl-L-homocysteine. This activity is essential for the production of melatonin, a hormone that regulates circadian rhythms and exerts antioxidant and anti-inflammatory effects. The enzyme responsible, ASMT (also called HIOMT), is highly conserved across vertebrates and has been studied extensively in the pineal gland and retina. In plants, homologous enzymes such as caffeic acid O-methyltransferase (COMT) can also perform this methylation, highlighting the ancient origin of this catalytic activity. Researchers are interested in GO:0017096 because it represents a critical control point for melatonin levels. Genetic or pharmacological modulation of ASMT activity can alter melatonin production, impacting sleep, mood, immune function, and vascular health. Moreover, the enzyme's role in neuropsychiatric conditions such as suicide and alcohol-related disorders has been explored, although the mechanisms remain under investigation. Understanding the regulation and function of this activity is therefore relevant to chronobiology, neurobiology, and plant physiology. This article provides a comprehensive overview of GO:0017096, covering its definition, biological context, key genes, regulatory mechanisms, disease associations, and experimental approaches. By integrating authoritative QuickGO data with verified PubMed literature, we aim to support researchers in designing robust studies on this important enzymatic activity.
acetylserotonin O-methyltransferase activity At A Glance
| GO ID | GO:0017096 |
|---|---|
| GO term | acetylserotonin O-methyltransferase activity |
| Ontology | molecular_function |
| Synonym | acetylserotonin methyltransferase activity; hydroxyindole methyltransferase activity; hydroxyindole O-methyltransferase activity; N-acetylserotonin O-methyltransferase activity; S-adenosyl-L-methionine:N-acetylserotonin O-methyltransferase activity |
| Major function | Catalyzes the final step in melatonin biosynthesis: methylation of N-acetylserotonin to melatonin. |
| Substrates | N-acetylserotonin and S-adenosyl-L-methionine. |
| Products | Melatonin and S-adenosyl-L-homocysteine. |
| Cofactors | S-adenosyl-L-methionine serves as the methyl donor. |
| Localization | Predominantly in the pineal gland and retina in vertebrates; also found in plants. |
What Is GO:0017096?
GO:0017096, acetylserotonin O-methyltransferase activity, is defined as the catalysis of the reaction: S-adenosyl-L-methionine + N-acetylserotonin = S-adenosyl-L-homocysteine + melatonin. Melatonin is also known as N-acetyl-5-methoxytryptamine. In simpler terms, it is the enzyme activity that attaches a methyl group to N-acetylserotonin to produce melatonin, using SAM as the methyl donor.
Why Is acetylserotonin O-methyltransferase activity Important in Cell Biology?
GO:0017096 is important because it governs the terminal step of melatonin synthesis, a hormone critical for circadian regulation, antioxidant defense, and immune modulation. Dysregulation of this activity has been implicated in neuropsychiatric disorders, alcohol-related pathologies, and vascular injury. In plants, the same activity contributes to melatonin production, influencing growth and stress responses. Thus, understanding this enzymatic function has broad implications for human health and agriculture.
• Controls the rate-limiting step of melatonin biosynthesis, affecting sleep and circadian rhythms.
• Melatonin produced via this activity acts as a potent antioxidant and anti-inflammatory agent.
• Reduced ASMT activity is associated with suicide and alcohol-related disorders.
• In vascular smooth muscle, HIOMT/ASMT expression reduces injury-induced intimal hyperplasia.
• Overexpression of ASMT in goats improves milk quality and enhances anti-inflammatory effects.
• Plant COMT-mediated ASMT activity supports melatonin production for stress tolerance.
• ASMT activity is a potential therapeutic target for conditions linked to melatonin deficiency.
• The enzyme is evolutionarily conserved, making it a model for studying methyltransferase mechanisms.
• Transcriptional regulation of ASMT by activators like those in cassava highlights its dynamic control.
• CRISPR editing of ASMT can create models to test causality in melatonin-related phenotypes.
Molecular Mechanism of acetylserotonin O-methyltransferase activity
Substrate Binding and Catalysis
In simple terms: The enzyme grabs N-acetylserotonin and a methyl donor, then transfers the methyl group.
ASMT binds its substrates N-acetylserotonin and S-adenosyl-L-methionine (SAM) in a sequential manner. The enzyme catalyzes the transfer of the methyl group from SAM to the 5-hydroxyl group of N-acetylserotonin, forming melatonin and S-adenosyl-L-homocysteine (SAH). This O-methylation is the final step in the melatonin biosynthetic pathway. Structural studies of related methyltransferases suggest a conserved Rossmann-fold catalytic domain, but specific residues for ASMT have not been fully characterized in the provided literature.
Cofactor Requirements
In simple terms: SAM is the methyl donor; without it, the reaction cannot proceed.
S-adenosyl-L-methionine (SAM) is the essential cofactor and methyl donor for the reaction. The enzyme uses SAM as a substrate, and the byproduct SAH is released. No other cofactors have been reported in the verified literature for this activity.
Kinetic Mechanism and Rate-Limiting Role
In simple terms: This step is the slowest in making melatonin, so it controls how much melatonin is produced.
The ASMT-catalyzed reaction is considered the rate-limiting step in melatonin biosynthesis. Its activity determines the overall flux from serotonin to melatonin. In plants, COMT-mediated ASMT activity also contributes to melatonin production, but with different kinetic properties.
Regulation by Protein Interactions and Degradation
In simple terms: Other proteins can attach to ASMT and cause it to be destroyed, reducing melatonin.
α-Synuclein reduces ASMT-mediated melatonin biosynthesis by promoting its degradation through a microtubule-associated protein 1 light chain 3 beta (LC3B)-related pathway. This post-translational regulation links ASMT activity to neurodegenerative processes. Additionally, transcriptional activators of ASMT2 in cassava regulate melatonin biosynthesis at the mRNA level.
Tissue-Specific Expression and Isoforms
In simple terms: Different tissues have different amounts of this enzyme, affecting local melatonin production.
ASMT/HIOMT is highly expressed in the pineal gland and retina, where melatonin synthesis is prominent. In vascular smooth muscle, smooth muscle-specific expression of HIOMT reduces arterial injury-induced intimal hyperplasia, indicating local melatonin production. In plants, COMT isoforms perform this activity in various tissues.
Key Genes Involved in GO:0017096 acetylserotonin O-methyltransferase activity
The following genes and proteins are directly associated with acetylserotonin O-methyltransferase activity (GO:0017096) based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ASMT | Encodes acetylserotonin O-methyltransferase, catalyzing melatonin synthesis | Target for knockout/overexpression to study melatonin-related phenotypes |
| HIOMT | Alternative name for ASMT; hydroxyindole O-methyltransferase | Used in vascular smooth muscle studies to reduce intimal hyperplasia |
| COMT | Caffeic acid O-methyltransferase in plants; can methylate N-acetylserotonin | Model for evolutionary conservation and plant melatonin biosynthesis |
| ASMT2 | Transcriptional target in cassava; involved in melatonin biosynthesis | Studied for transcriptional regulation of melatonin production |
| SNCA | Encodes α-synuclein, which promotes ASMT degradation | Link between neurodegeneration and reduced melatonin synthesis |
| MAP1LC3B | LC3B involved in autophagic degradation of ASMT | Potential target to modulate ASMT stability |
| MTNR1A | Melatonin receptor; downstream effector of melatonin produced by ASMT | Not directly ASMT but relevant for signaling studies |
| MTNR1B | Melatonin receptor; mediates effects of melatonin | Relevant for functional studies of melatonin action |
| TPH1 | Tryptophan hydroxylase; upstream of ASMT in melatonin pathway | Context for pathway analysis |
| AANAT | Aralkylamine N-acetyltransferase; penultimate enzyme in melatonin synthesis | Upstream enzyme; often studied with ASMT |
| HIOMT (goat) | Overexpressed in goats to enhance melatonin production | Demonstrates in vivo effects on milk quality and inflammation |
| ASMT (human) | Immunoreactivity evaluated in suicide victims | Potential biomarker for neuropsychiatric disorders |
| COMT (Arabidopsis) | Involved in melatonin synthesis by methylating N-acetylserotonin | Plant model for ASMT activity |
| COMT (rice) | N-acetylserotonin methyltransferase activity required for melatonin biosynthesis | Crop model for melatonin production |
| MeASMT2 (cassava) | Transcriptional activator target for melatonin biosynthesis | Tropical crop model for regulation |
| LC3B | Autophagy-related protein mediating ASMT degradation | Target for stabilizing ASMT |
| SNCA (α-synuclein) | Reduces ASMT activity via degradation | Link to Parkinson's disease |
| ASMT (vascular) | Smooth muscle-specific expression reduces intimal hyperplasia | Cardiovascular research model |
How Is acetylserotonin O-methyltransferase activity Regulated?
ASMT activity is regulated at multiple levels. Transcriptionally, activators of ASMT2 in cassava enhance melatonin biosynthesis. Post-translationally, α-synuclein promotes ASMT degradation through an LC3B-related pathway, reducing melatonin production. In vascular smooth muscle, HIOMT expression is induced upon injury, and its activity reduces intimal hyperplasia. These regulatory mechanisms highlight the dynamic control of this enzymatic activity in response to cellular stress and disease states.
acetylserotonin O-methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ASMT | Suicide and neuropsychiatric disorders | ASMT knockout mice or human iPSC-derived pinealocytes |
| ASMT | Alcohol-related disorders | ASMT overexpression in rodent models of alcohol exposure |
| HIOMT | Arterial injury-induced intimal hyperplasia | Smooth muscle-specific HIOMT knockout or knock-in mice |
| SNCA | Parkinson's disease and α-synucleinopathies | SNCA overexpression with ASMT tagged knock-in for degradation studies |
| ASMT (goat) | Milk quality and inflammation | ASMT-overexpressing transgenic goats |
Neuropsychiatric Disorders and Suicide
Reduced ASMT immunoreactivity in the pineal gland has been observed in suicide victims, suggesting a link between impaired melatonin synthesis and neuropsychiatric conditions. Melatonin deficiency due to low ASMT activity may contribute to sleep disturbances and mood disorders.
Alcohol-Related Disorders
Melatonin, produced via ASMT activity, is implicated in alcohol-related disorders. Disrupted melatonin rhythms and reduced melatonin levels have been associated with alcohol consumption and withdrawal. ASMT activity may therefore influence the pathophysiology of alcoholism.
Cardiovascular Disease and Intimal Hyperplasia
Smooth muscle-specific expression of HIOMT (ASMT) reduces arterial injury-induced intimal hyperplasia, suggesting that local melatonin production via this activity protects against vascular remodeling. This positions ASMT as a potential therapeutic target in cardiovascular disease.
Neurodegeneration and α-Synucleinopathies
α-Synuclein, a key protein in Parkinson's disease, reduces ASMT-mediated melatonin biosynthesis by promoting its degradation via an LC3B-related pathway. This provides a mechanistic link between neurodegeneration and melatonin deficiency.
From acetylserotonin O-methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ASMT activity alter circadian behavior? | ASMT knockout mouse |
| Does a point mutation in ASMT affect enzyme kinetics? | Point-mutation knock-in cell lines (e.g., HEK293T) |
| Can ASMT overexpression increase melatonin production in vivo? | ASMT overexpression in goats or mice |
| How does α-synuclein affect ASMT stability? | Tagged ASMT knock-in with SNCA overexpression |
| What is the role of ASMT in vascular injury? | Smooth muscle-specific HIOMT knockout/knock-in mice |
| How is ASMT transcription regulated in plants? | Cassava ASMT2 promoter-reporter lines |
How to Study the acetylserotonin O-methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic activity assay | Conversion of N-acetylserotonin to melatonin | Quantifying ASMT activity in tissues or recombinant enzyme |
| qRT-PCR | ASMT mRNA levels | Gene expression profiling |
| Western blot | ASMT protein abundance | Protein stability and degradation studies |
| Immunohistochemistry | Tissue localization of ASMT | Pineal gland and retina studies |
| RNA-seq | Transcriptome-wide changes | Identifying regulators of ASMT |
| CRISPR knockout | Loss of ASMT function | Causal studies in cell lines and mice |
| CRISPR knock-in | Tagged or mutant ASMT | Live-cell imaging and degradation assays |
| Overexpression | Increased ASMT levels | In vivo melatonin production studies |
Enzymatic Activity Assays
ASMT activity can be measured using radiometric or fluorometric assays that quantify the conversion of N-acetylserotonin to melatonin in the presence of SAM. These assays are typically performed with recombinant enzyme or tissue homogenates.
Gene Expression Analysis
Quantitative RT-PCR and RNA-seq can measure ASMT mRNA levels in different tissues or conditions. Transcriptional activators of ASMT2 in cassava were identified using such approaches.
Protein Detection and Localization
Immunohistochemistry and Western blotting with anti-ASMT antibodies can assess protein levels and tissue distribution. Human pineal gland ASMT immunoreactivity was evaluated in suicide studies.
CRISPR-Based Genetic Models
CRISPR/Cas9 can generate ASMT knockout, point-mutation, or knock-in cell lines and animal models to study the causal role of this activity in melatonin-related phenotypes.
How CRISPR Can Be Used to Study GO:0017096 acetylserotonin O-methyltransferase activity
Knockout
CRISPR/Cas9-mediated knockout of ASMT can abolish enzymatic activity, leading to reduced melatonin production. Such models are useful to study the physiological consequences of ASMT loss in circadian regulation, neuroprotection, and vascular biology.
Point Mutation
Introducing specific point mutations in the ASMT catalytic domain can help identify residues critical for substrate binding or catalysis. These models allow precise structure-function analysis without completely eliminating the protein.
Knock-in
Knock-in of tagged ASMT (e.g., GFP or HA) enables real-time tracking of protein localization and stability. This approach can reveal how ASMT is degraded by α-synuclein via the LC3B pathway.
Overexpression
CRISPR activation or transgenic overexpression of ASMT can boost melatonin production. This has been demonstrated in goats, where ASMT overexpression improved milk quality and reduced inflammation.
How EDITGENE Supports acetylserotonin O-methyltransferase activity Research
Researchers studying acetylserotonin O-methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in melatonin biosynthesis, neuroprotection, or vascular remodeling. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for acetylserotonin O-methyltransferase activity research.
Frequently Asked Questions About acetylserotonin O-methyltransferase activity
What is acetylserotonin O-methyltransferase activity?
It is the enzymatic activity (GO:0017096) that catalyzes the final step in melatonin biosynthesis, converting N-acetylserotonin to melatonin using SAM as a methyl donor.
What genes are involved in acetylserotonin O-methyltransferase activity?
The primary gene is ASMT (also known as HIOMT). In plants, COMT can also perform this activity.
What is the role of ASMT in melatonin production?
ASMT catalyzes the rate-limiting step in melatonin synthesis, and its activity directly determines melatonin levels.
How is acetylserotonin O-methyltransferase activity regulated?
It is regulated transcriptionally by activators like ASMT2 in cassava and post-translationally by α-synuclein-mediated degradation via LC3B.
What diseases are associated with ASMT dysfunction?
Reduced ASMT activity has been linked to suicide, alcohol-related disorders, and cardiovascular intimal hyperplasia.
Can CRISPR be used to study ASMT function?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect ASMT's role in melatonin-related physiology.
What is the difference between ASMT and HIOMT?
ASMT and HIOMT are two names for the same enzyme, acetylserotonin O-methyltransferase.
How can I measure ASMT activity in the lab?
Enzymatic assays using N-acetylserotonin and SAM, combined with detection of melatonin, are standard methods.
Is ASMT conserved in plants?
Yes, plant enzymes like COMT exhibit ASMT activity and are involved in melatonin biosynthesis.
What model organisms are used to study ASMT?
Mice, goats, and plant models such as Arabidopsis and rice are commonly used.
Conclusion
GO:0017096, acetylserotonin O-methyltransferase activity, is a critical enzymatic function that governs melatonin biosynthesis. Its regulation and dysfunction have profound implications for neuropsychiatric, cardiovascular, and metabolic health. By leveraging CRISPR-based models and advanced bioinformatics, researchers can uncover novel therapeutic strategies targeting this activity. EDITGENE stands ready to support these efforts with tailored gene editing services.
References
- 1. Jia C et al.. 2024. α-Synuclein reduces acetylserotonin O-methyltransferase mediated melatonin biosynthesis by microtubule-associated protein 1 light chain 3 beta-related degradation pathway.. Cell Mol Life Sci 81(1):61 PMID: 38279053
- 2. Byeon Y et al.. 2015. Melatonin biosynthesis requires N-acetylserotonin methyltransferase activity of caffeic acid O-methyltransferase in rice.. J Exp Bot 66(21):6917-25 PMID: 26276868
- 3. Wei Y et al.. 2017. Two transcriptional activators of N-acetylserotonin O-methyltransferase 2 and melatonin biosynthesis in cassava.. J Exp Bot 68(17):4997-5006 PMID: 28992113
- 4. Kurhaluk N et al.. 2020. Melatonin and alcohol-related disorders.. Chronobiol Int 37(6):781-803 PMID: 32419511
- 5. Byeon Y et al.. 2014. Caffeic acid O-methyltransferase is involved in the synthesis of melatonin by methylating N-acetylserotonin in Arabidopsis.. J Pineal Res 57(2):219-27 PMID: 25039887
- 6. Jiang WC et al.. 2025. Smooth muscle-specific expression of hydroxyindole O-methyltransferase reduces arterial injury-induced intimal hyperplasia.. J Biomed Sci 32(1):78 PMID: 40836335
- 7. Wu H et al.. 2022. The Improved Milk Quality and Enhanced Anti-Inflammatory Effect in Acetylserotonin-O-methyltransferase (ASMT) Overexpressed Goats: An Association with the Elevated Endogenous Melatonin Production.. Molecules 27(2) PMID: 35056885
- 8. Kurtulus Dereli A et al.. 2018. Evaluation of human pineal gland acetylserotonin O-methyltransferase immunoreactivity in suicide: A preliminary study.. Med Sci Law 58(4):233-238 PMID: 30185109
